About the Authors

Jessica L. Montoya

Affiliation Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America

Nicole Landi

Affiliations Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut, United States of America, Haskins Laboratories, New Haven, Connecticut, United States of America

Hedy Kober

Affiliation Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America

Patrick D. Worhunsky

Affiliation Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America

Helena J. V. Rutherford

Affiliation Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut, United States of America

W. Einar Mencl

Affiliation Haskins Laboratories, New Haven, Connecticut, United States of America

Linda C. Mayes

Affiliations Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America, Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut, United States of America

Marc N. Potenza

marc.potenza@yale.edu

Affiliations Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America, Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America

Competing Interests

MNP has consulted for and advised Boehringer Ingelheim; has consulted for and has financial interests in Somaxon; has received research support from Mohegan Sun Casino, the National Center for Responsible Gaming and its affiliated Institute for Research on Gambling Disorders, and Forest Laboratories, Ortho-McNeil, Oy-Control/Biotie, Glaxo-SmithKline and Psyadon pharmaceuticals; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for law offices and the federal public defender’s office in issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has guest-edited journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. A list of published titles is available on request. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: NL WEM LCM MNP. Performed the experiments: JLM NL LCM. Analyzed the data: JLM HK PDW. Contributed reagents/materials/analysis tools: LCM MNP. Wrote the paper: JLM NL HK PDW HJVR WEM LCM MNP.